MENU
+Compare
PCRX
Stock ticker: NASDAQ
AS OF
Jun 26, 03:31 PM (EDT)
Price
$23.52
Change
-$0.39 (-1.63%)
Capitalization
1.36B

PCRX Pacira BioSciences Forecast, Technical & Fundamental Analysis

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients... Show more

PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PCRX with price predictions
Jun 25, 2025

PCRX sees its Stochastic Oscillator recovers from oversold territory

On June 24, 2025, the Stochastic Oscillator for PCRX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PCRX advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

PCRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 158 cases where PCRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PCRX as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PCRX turned negative on June 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

PCRX moved below its 50-day moving average on June 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PCRX crossed bearishly below the 50-day moving average on June 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.557) is normal, around the industry mean (62.463). P/E Ratio (32.742) is within average values for comparable stocks, (89.614). PCRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (2.244) is also within normal values, averaging (19.198).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PCRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PCRX is expected to report earnings to rise 10.15% to 68 cents per share on August 05

Pacira BioSciences PCRX Stock Earnings Reports
Q2'25
Est.
$0.68
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.20
The last earnings report on May 08 showed earnings per share of 62 cents, beating the estimate of 58 cents. With 178.54K shares outstanding, the current market capitalization sits at 1.36B.
A.I. Advisor
published General Information

General Information

a manufacturer of injectable therapeutic products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
5401 West Kennedy Boulevard
Phone
+1 813 553-6680
Employees
713
Web
https://www.pacira.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFAIX27.69N/A
N/A
Morgan Stanley Inst Intl Advtg I
EPGIX13.49N/A
N/A
EuroPac Gold I
QRSIX40.95N/A
N/A
FPA Queens Road Small Cap Value Instl
FFBGX39.03-0.05
-0.13%
American Funds Global Balanced 529-F-3
USPCX28.85-0.08
-0.28%
Union Street Partners Value C

PCRX and Stocks

Correlation & Price change

A.I.dvisor tells us that PCRX and ELAN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRX and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCRX
1D Price
Change %
PCRX100%
-2.88%
ELAN - PCRX
32%
Poorly correlated
+1.85%
TEVA - PCRX
28%
Poorly correlated
-0.53%
ACET - PCRX
27%
Poorly correlated
+0.58%
SNDL - PCRX
26%
Poorly correlated
-1.61%
NBIX - PCRX
25%
Poorly correlated
-0.31%
More